关注
Nick Bansback
Nick Bansback
School of Population and Public Health, University of British Columbia
在 ubc.ca 的电子邮件经过验证
标题
引用次数
年份
" Walking into the unknown horizontal ellipsis" key challenges of pregnancy and early parenting with inflammatory arthritis: a systematic review and thematic synthesis of …
N Rebic, R Garg, U Ellis, V Kitchin, S Munro, G Hazlewood, N Amiri, ...
ARTHRITIS RESEARCH & THERAPY 23 (1), 2021
2021
“Walking into the unknown…” key challenges of pregnancy and early parenting with inflammatory arthritis: a systematic review and thematic synthesis of qualitative studies
N Rebić, R Garg, U Ellis, V Kitchin, S Munro, G Hazlewood, N Amiri, ...
Arthritis research & therapy 23 (1), 1-18, 2021
42021
A Comparison of Ordered Categorical versus Discrete Choices within a Stated Preference Survey of Whole-Blood Donors
Z Sadique, J Cairns, K De Corte, S Willis, A Miners, N Bansback, R Grieve
Medical Decision Making 43 (3), 362-373, 2023
12023
A comparison of three strategies to reduce the burden of osteoarthritis: A population-based microsimulation study
JA Kopec, EC Sayre, A Okhmatovskaia, J Cibere, LC Li, N Bansback, ...
Plos one 16 (12), e0261017, 2021
22021
A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly
G Osterhoff, NN O’Hara, J D’Cruz, SA Sprague, N Bansback, N Evaniew, ...
Value in Health 20 (3), 404-411, 2017
562017
A measurement framework for adherence in patient decision aid trials applied in a systematic review subanalysis
L Trenaman, A Selva, S Desroches, K Singh, J Bissonnette, N Bansback, ...
Journal of Clinical Epidemiology 77, 15-23, 2016
202016
A pharmacoeconomic review of adalimumab in the treatment of rheumatoid arthritis
N Bansback, A Brennan, AH Anis
Expert Review of Pharmacoeconomics and Outcomes Research 5 (5), 519-529, 2005
52005
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration
J Karnon, C Czoski-Murray, K Smith, C Brand, U Chakravarthy, S Davis, ...
HEALTH TECHNOLOGY ASSESSMENT-SOUTHAMPTON- 12 (27), 2008
352008
A prognostic model for functional outcome in early rheumatoid arthritis.
N Bansback, A Young, A Brennan, J Dixey
The Journal of Rheumatology 33 (8), 1503-1510, 2006
432006
A rapid and systematic review of the clinical effectiveness and cost effectiveness of gemcitabine for the treatment of pancreatic cancer
S Ward, E Morris, N Bansback, N Calvert, A Crellin, D Forman, M Larvin
Core Research, 2001
352001
A rapid and systematic review of the evidence and cost-effectiveness of irinotecan, oxaliplatine and raltitrexed for the treatment of advanced colorectal cancer
LM Jones, S Hummel, N Bansback, B Orr, N Seymour
Health Technol Assess 5, 99-100, 2001
42001
A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced …
M Lloyd Jones, S Hummel, N Bansback, B Orr
Health Technol Assess 5 (25), 1-128, 2001
25*2001
A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care
NK Biln, N Bansback, K Shojania, L Puil, M Harrison
Rheumatology International, 1-14, 2024
2024
A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada
F Xie, E Pullenayegum, K Gaebel, N Bansback, S Bryan, A Ohinmaa, ...
Medical care 54 (1), 98-105, 2016
3692016
Adaptation of a Shared Decision-Making Tool for Early Rheumatoid Arthritis Treatment Decisions with Indigenous Patients
V Umaefulam, TL Fox, G Hazlewood, N Bansback, CEH Barber, ...
The Patient-Patient-Centered Outcomes Research 15 (2), 233-243, 2022
52022
Adherence to antitumor necrosis factor use recommendations in spondyloarthritis: measurement and effect in the DESIR Cohort
S Harvard, D Guh, N Bansback, P Richette, A Saraux, B Fautrel, AH Anis
The Journal of rheumatology 44 (10), 1436-1444, 2017
22017
An economic valuation technique identified different inpatient care experience as priorities for older Canadians than a traditional approach
L Trenaman, S Bryan, L Cuthbertson, R Sawatzky, D Stacey, N Bansback
Journal of Clinical Epidemiology 139, 1-11, 2021
2021
An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a …
N Bansback, L Trenaman, KV MacDonald, G Hawker, JA Johnson, ...
BMC musculoskeletal disorders 20 (1), 1-10, 2019
442019
An online individualised patient decision aid improves the quality of decisions in patients considering total knee arthroplasty in routine care: a randomized controlled trial
N Bansback, L Trenaman, KV MacDonald, G Hawker, JA Johnson, ...
Osteoarthritis and Cartilage Open 4 (3), 100286, 2022
142022
An overview of economic evaluations for drugs used in rheumatoid arthritis: focus on tumour necrosis factor-alpha antagonists
NJ Bansback, DA Regier, R Ara, A Brennan, K Shojania, JM Esdaile, ...
Drugs 65 (4), 473-496, 2005
982005
系统目前无法执行此操作,请稍后再试。
文章 1–20